These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 31310826)

  • 1. Efficacy and safety of photodynamic therapy with amino-5-laevulinate nanoemulsion versus methyl-5-aminolaevulinate for actinic keratosis: A meta-analysis.
    Fu C; Kuang BH; Qin L; Zeng XY; Wang BC
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():408-414. PubMed ID: 31310826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis.
    Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Hahn S; Pabst G; Voss D; Foguet M; Schmitz B; Lübbert H; Szeimies RM; ;
    Br J Dermatol; 2013 Apr; 168(4):825-36. PubMed ID: 23252768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-aminolaevulinic acid nanoemulsion is more effective than methyl-5-aminolaevulinate in daylight photodynamic therapy for actinic keratosis: a nonsponsored randomized double-blind multicentre trial.
    Räsänen JE; Neittaanmäki N; Ylitalo L; Hagman J; Rissanen P; Ylianttila L; Salmivuori M; Snellman E; Grönroos M
    Br J Dermatol; 2019 Aug; 181(2):265-274. PubMed ID: 30329163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate.
    Neittaanmäki-Perttu N; Karppinen TT; Grönroos M; Tani TT; Snellman E
    Br J Dermatol; 2014 Nov; 171(5):1172-80. PubMed ID: 25109244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
    Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
    Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis.
    Dirschka T; Ekanayake-Bohlig S; Dominicus R; Aschoff R; Herrera-Ceballos E; Botella-Estrada R; Hunfeld A; Kremser M; Schmitz B; Lübbert H; Puig S
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):288-297. PubMed ID: 30022544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.
    Reinhold U; Dirschka T; Ostendorf R; Aschoff R; Berking C; Philipp-Dormston WG; Hahn S; Lau K; Jäger A; Schmitz B; Lübbert H; Szeimies RM
    Br J Dermatol; 2016 Oct; 175(4):696-705. PubMed ID: 26921093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial.
    Gutiérrez García-Rodrigo C; Pellegrini C; Piccioni A; Tambone S; Fargnoli MC
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():100-104. PubMed ID: 31141730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daylight versus conventional photodynamic therapy for the treatment of actinic keratosis: A meta-analysis of randomized controlled trials.
    Mei X; Wang L; Zhang R; Zhong S
    Photodiagnosis Photodyn Ther; 2019 Mar; 25():23-28. PubMed ID: 30412779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized intraindividual comparative study of methyl-5-aminolaevulinate vs. 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) in photodynamic therapy for actinic keratosis of the face and scalp.
    Serra-Guillén C; Nagore E; Bancalari E; Kindem S; Sanmartín O; Llombart B; Requena C; Serra-Guillén I; Calomarde L; Diago A; Bernia E; Guillén C
    Br J Dermatol; 2018 Dec; 179(6):1410-1411. PubMed ID: 30019337
    [No Abstract]   [Full Text] [Related]  

  • 11. Photodynamic therapy with methyl-5-aminolevulinate for basal cell carcinoma: A systematic review and meta-analysis.
    Wang BC; Fu C; Qin L; Zeng XY; Liu Q
    Photodiagnosis Photodyn Ther; 2020 Mar; 29():101667. PubMed ID: 31978564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions for actinic keratoses.
    Gupta AK; Paquet M; Villanueva E; Brintnell W
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD004415. PubMed ID: 23235610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain during topical photodynamic therapy - comparing methyl aminolevulinate (Metvix
    Yazdanyar S; Zarchi K; Jemec GBE
    Photodiagnosis Photodyn Ther; 2017 Dec; 20():6-9. PubMed ID: 28780136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of BF-200 ALA for the photodynamic treatment of mild-to-moderate actinic keratosis.
    Reinhold U
    Future Oncol; 2017 Nov; 13(27):2413-2428. PubMed ID: 28805092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis.
    Babilas P
    Br J Dermatol; 2013 Apr; 168(4):686-7. PubMed ID: 23528055
    [No Abstract]   [Full Text] [Related]  

  • 16. Comment on "Efficacy and safety of photodynamic therapy with amino-5-laevulinate nanoemulsion versus methyl-5-aminolaevulinate for actinic keratosis: A meta-analysis".
    Li L; Jiang T; Ji H; Sun P
    Photodiagnosis Photodyn Ther; 2020 Dec; 32():101507. PubMed ID: 31336180
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative study of trichloroacetic acid vs. photodynamic therapy with topical 5-aminolevulinic acid for actinic keratosis of the scalp.
    Di Nuzzo S; Cortelazzi C; Boccaletti V; Zucchi A; Conti ML; Montanari P; Feliciani C; Fabrizi G; Pagliarello C
    Photodermatol Photoimmunol Photomed; 2015 Sep; 31(5):233-8. PubMed ID: 25660106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized split-scalp study comparing calcipotriol-assisted methyl aminolaevulinate photodynamic therapy (MAL-PDT) with conventional MAL-PDT for the treatment of actinic keratosis.
    Torezan L; Grinblat B; Haedersdal M; Valente N; Festa-Neto C; Szeimies RM
    Br J Dermatol; 2018 Oct; 179(4):829-835. PubMed ID: 29476546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Home- vs clinic-based daylight photodynamic therapy with 5-aminolevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis: A randomized, single-blind, prospective study.
    Saenz-Guirado S; Ayen-Rodriguez A; Galvez-Moreno M; Velasco-Amador JP; Llamas-Molina JM; Ruiz-Villaverde R; Molina-Leyva A
    Photodiagnosis Photodyn Ther; 2024 Apr; 46():104031. PubMed ID: 38438001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined daylight and conventional photodynamic therapy with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis of the face and scalp: a new and efficient approach.
    Salido-Vallejo R; Jiménez-Nájar F; Garnacho-Sucedo G; Vélez A
    Arch Dermatol Res; 2020 Nov; 312(9):675-680. PubMed ID: 31838569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.